Announcements Trials
Browse Landscape

Phase

Phase NA 79Phase 2 30Phase 3 19Phase 1/2 5Phase 2/3 4Phase 1 4Phase 4 2

Status

Completed 7Unknown 3Recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1

Conditions

Multiple Myeloma 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Propofol 9Sevoflurane 7Rituximab 7Specimen Handling 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Trastuzumab 5Enoxaparin 5Bevacizumab 5Nivolumab 4Carboplatin 4Capecitabine 4Bupivacaine 4trametinib 3pirtobrutinib 3pembrolizumab 3dabrafenib 3atezolizumab 3apixaban 3Lenalidomide 3Indocyanine Green 3Gemcitabine 3Docetaxel 3Cyclophosphamide 3zanubrutinib 2venetoclax 2trastuzumab deruxtecan 2ribociclib 2polyethylene glycol 3350 2pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recruiting × Standard of Care × Clear all
NCT07094048 2026-01-07

CHUQUL_HO001

CHU de Quebec-Universite Laval

Phase 4 Recruiting
80 enrolled
Plasma cell

Multiple Myeloma

NCT06903312 2025-07-03

ITALIC-RCC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 4 Recruiting
409 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡